You are viewing: Rest Of Europe ECMO Machines Market analysis
Part of: ECMO Machines Market (Global)

The Rest Of Europe ECMO Machines Market was valued at $131.3 Million in 2025 and projected to reach to $180 Million by 2030, representing a compound annual growth rate of 6.5%. Rest of Europe's ECMO machines market is positioned for steady expansion through 2030, driven by increasing recognition of extracorporeal membrane oxygenation as a critical intervention for severe cardiopulmonary failure.

Rest Of Europe ECMO Machines Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Rest Of Europe ECMO Machines Market Trends and Insights

  • Asia Pacific's growth trajectory reflects increasing adoption of extracorporeal membrane oxygenation technology across critical care settings, driven by rising prevalence of respiratory and cardiac complications.
  • The region's healthcare infrastructure modernization and growing investment in advanced life support systems are positioning Asia Pacific as a high-growth market segment. Asia Pacific's 6.5% compound annual growth rate outpaces global benchmarks, underscoring strong regional demand for ECMO devices.
  • Between 2025 and 2030, Asia Pacific is expected to capture significant market share through expanded hospital capacity, improved reimbursement frameworks, and heightened clinical awareness.
  • Asia Pacific's emerging economies are increasingly recognizing ECMO as a critical intervention for severe cardiopulmonary failure, particularly in pandemic preparedness and trauma management protocols..

Key Market Statistics

  • CAGR (2025-2030) 6.5% CAGR
  • Market Size, 2025 ~USD 131.3 Million
  • Forecast, 2030 ~USD 180 Million
  • Country Rest Of Europe

Rest Of Europe ECMO Machines Market Overview

Market Valuation :

Rest of Europe's ECMO machines market is valued at USD 131.3 million in 2025, demonstrating significant healthcare investment in advanced critical care technologies across smaller European economies.

Growth Trajectory :

The region is projected to reach USD 180.0 million by 2030, representing a robust 6.5% CAGR, outpacing the global average of 5.8% and indicating accelerating adoption of extracorporeal membrane oxygenation technology.

Healthcare Infrastructure Development :

Rest of Europe is witnessing modernization of critical care facilities, with increasing investment in ECMO capabilities to support treatment of severe respiratory and cardiac conditions in secondary and tertiary care centers.

Clinical Demand Drivers :

Rising prevalence of acute respiratory distress syndrome, post-COVID complications, and complex cardiac conditions are driving demand for ECMO machines across Rest of Europe's healthcare systems.

Rest Of Europe ECMO Machines Market Dynamics

  • Healthcare providers across the region are investing in ECMO infrastructure to enhance their critical care capabilities and improve patient outcomes in complex cases.
  • The 6.5% CAGR reflects growing clinical adoption and regulatory support for advanced life support technologies. Market growth will be supported by rising healthcare expenditures, improved reimbursement policies, and collaborative efforts to establish ECMO centers of excellence across smaller European nations.
  • Training initiatives and technology partnerships with leading manufacturers are expected to accelerate market penetration, while increasing awareness among clinicians about ECMO's therapeutic benefits will drive sustained demand through the forecast period..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • Asia Pacific ECMO machines market valued at USD 131.3 million in 2025, expanding to USD 180.0 million by 2030
    • Asia Pacific demonstrates 6.5% CAGR, outperforming global market growth rates
    • Asia Pacific's healthcare modernization and critical care expansion drive sustained ECMO adoption
    • Asia Pacific emerging markets increasingly prioritize ECMO for severe cardiopulmonary failure management

    ECMO Machines Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR) (Application)
    Forecast Period 2025–2030
    Growth Rate CAGR of 5.8% from 2025 to 2030
    Largest Segment ADULT PATIENTS (Patient Type)
    Market Size Base Year (Billions) ~USD 0.65 (2025)
    Revenue Forecast (Billions) ~USD 0.86 (2030)
    Segments Covered Product, Type, Modality, Patient Type, Application, End User

    Rest Of Europe ECMO Machines Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Components
    • Machines

    By Type

    • Accessories
    • Cannulas
    • Controllers
    • Oxygenators
    • Pumps

    By Modality

    • Arteriovenous Ecmo
    • Venoarterial Ecmo
    • Venovenous Ecmo

    By Patient Type

    • Adult Patients
    • Neonates
    • Pediatric Patients

    By Application

    • Cardiac Applications
    • Extracorporeal Cardiopulmonary Resuscitation (Ecpr)
    • Respiratory Applications

    By End User

    • Academic & Research Institutions
    • Hospitals
    • Specialty Clinics

    Target Audience

    • Medical Device Manufacturers : ECMO equipment producers need Rest of Europe-specific market data to develop localized go-to-market strategies, identify distribution partners, and forecast revenue potential in this growing regional segment.
    • Healthcare System Administrators : Hospital networks and health authorities require regional market insights to justify ECMO infrastructure investments, plan critical care capacity expansion, and align procurement with clinical demand trends.
    • Investment & Private Equity Firms : Investors evaluating healthcare technology opportunities need Rest of Europe market intelligence to assess growth potential, competitive dynamics, and return on investment in ECMO-related ventures.
    • Clinical Research Organizations : CROs and academic institutions conducting ECMO studies require regional market data to understand adoption patterns, identify research gaps, and design relevant clinical trials for Rest of Europe populations.
    • Healthcare Consultants & Analysts : Strategy consultants advising healthcare clients need Rest of Europe-specific ECMO market forecasts to develop evidence-based recommendations for critical care service expansion and technology adoption.

    Key Companies in the Rest Of Europe ECMO Machines Market

    CompanyHQOwnershipStrongest segments
    GETINGESwedenPublic CompanyAcute Care Therapies,Surgical Workflows,Life Science,
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),
    TERUMO CORPORATIONJapanPublic CompanyCardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company,
    FRESENIUS MEDICAL CARE AGGermanyPublic CompanyDialysis services (outpatient and in-hospital ESRD/acute),Dialysis machines, cyclers, and water treatment systems,Dialysis consumables and solutions,
    LIVANOVA PLCUnited KingdomPublic CompanyCardiopulmonary (heart-lung machines, oxygenators, autotransfusion, perfusion tubing, cannula, services),Neuromodulation (VNS Therapy for epilepsy and depression, aura6000 development),
    NIPROJapanPublic CompanyDialysis products and artificial organ-related devices,Injection and infusion products, hospital and diabetic products, functional products,Pharmaceutical-Related (CDMO for injectables and oral drugs, kit products),
    WEIGAO GROUP CO., LTD.ChinaPublic CompanyMedical Device Products (infusion, clinical nursing, perioperative, urinary, rehab, extracorporeal circulation),Orthopedic Products (spine, joint, trauma, sports medicine, bone repair, spinal endoscope),Pharma Packaging Products (prefilled systems, packaging consumables, automatic drug delivery),
    ABBOTTUnited StatesPublic CompanyDiagnostic Products,Medical Devices,Nutritional Products,
    MICROPORT SCIENTIFIC CORPORATIONChinaPublic CompanyCardiovascular Devices,Orthopedics Devices,Cardiac Rhythm Management,

    GETINGE

    Getinge is a Swedish public company founded in 1904 that employs 11,754 people and operates in the medical technology sector.

    MEDTRONIC

    Medtronic is a public company headquartered in Ireland, founded in 1949, with approximately 95,000 employees specializing in medical devices and healthcare solutions.

    TERUMO CORPORATION

    Terumo Corporation is a Japanese public company established in 1921 with 30,591 employees, operating in the medical device and healthcare industry.

    FRESENIUS MEDICAL CARE AG

    Fresenius Medical Care AG is a German public company founded in 1996 with 108,165 employees, providing dialysis and renal care services globally.

    LIVANOVA PLC

    LivaNova PLC is a United Kingdom-based public company founded in 2015 with 3,300 employees, focused on neuromodulation and cardiac surgery solutions.

    NIPRO

    Nipro is a Japanese public company established in 1947 with 38,593 employees, manufacturing medical devices and pharmaceutical products.

    WEIGAO GROUP CO., LTD.

    Weigao Group Co., Ltd. is a Chinese public company founded in 1988 with 13,307 employees, specializing in medical device manufacturing.

    ABBOTT

    Abbott is a United States-based public company founded in 1888 with 115,000 employees, operating across diagnostics, medical devices, nutrition, and pharmaceuticals.

    MICROPORT SCIENTIFIC CORPORATION

    MicroPort Scientific Corporation is a Chinese public company established in 1998 with 6,547 employees, developing and manufacturing medical devices.

    Reasons to Buy this Report

    • Regional Market Sizing : Obtain precise valuation data specific to Rest of Europe's ECMO market, enabling accurate budget allocation and investment decisions tailored to this distinct regional segment.
    • Growth Opportunity Assessment : Understand the 6.5% CAGR trajectory and identify high-potential markets within Rest of Europe for product launches, partnerships, and expansion strategies through 2030.
    • Competitive Positioning : Benchmark your ECMO solutions against regional demand patterns and healthcare infrastructure development to optimize market entry and competitive differentiation strategies.
    • Clinical Adoption Insights : Gain intelligence on rising prevalence of respiratory and cardiac complications driving ECMO adoption across Rest of Europe's critical care settings and patient populations.
    • Strategic Planning Data : Access actionable forecasts and market dynamics specific to Rest of Europe to inform long-term business strategy, resource allocation, and stakeholder communications.

    Frequently asked questions

    What is the current market size of ECMO machines in Asia Pacific?

    Asia Pacific's ECMO machines market is valued at USD 131.3 million in 2025, representing significant regional demand for advanced life support technologies.

    What is the projected market size for Asia Pacific ECMO machines by 2030?

    Asia Pacific's ECMO machines market is forecast to reach USD 180.0 million by 2030, reflecting sustained growth in critical care infrastructure.

    What is the CAGR for Asia Pacific ECMO machines market?

    Asia Pacific's ECMO machines market is projected to grow at a 6.5% compound annual growth rate from 2025 to 2030.

    Which factors are driving ECMO adoption in Asia Pacific?

    Asia Pacific's ECMO growth is driven by healthcare infrastructure modernization, rising respiratory and cardiac complications, improved reimbursement, and pandemic preparedness initiatives.

    How does Asia Pacific's ECMO market compare to global trends?

    Asia Pacific's 6.5% CAGR exceeds the global market growth rate of 5.8%, positioning the region as a high-growth segment within the international ECMO market.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size of the ECMO machines market. Exhaustive secondary research was done to collect information on the ECMO market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the ECMO market.

    Secondary Research

    This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and companies’ house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the ECMO market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the ECMO market. Primary sources from the demand side included hospitals, academic & research institutions, specialty clinics, researchers, lab technicians, purchase managers, and stakeholders in corporate & government bodies.

    The following is a breakdown of the primary respondents:

    ECMO Machines Market

    Note 1: C-level primaries include CEOs, COOs, and CTOs.

    Note 2: Others include sales managers, marketing managers, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=< USD 500 million

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the ECMO market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    ECMO Machines Market

    Data Triangulation

    The entire market was split into three segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at precise statistics for all segments.

    Approach to derive the market size and estimate market growth.

    Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of ECMO machines and components. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

    Market Definition

    An ECMO machine acts as an artificial heart and lung for a patient whose heart or lungs cannot provide enough blood flow or oxygen into the blood. ECMO is used after other methods of supporting the heart and lungs do not work. The goal of ECMO is to let the heart and lungs recover while the patient is supported by the ECMO machine.

    Stakeholders

    • Manufacturers of ECMO Machine Products and Related Devices
    • Suppliers and Distributors of ECMO Machine Devices
    • Hospitals, Clinics, and Medical Colleges
    • Medical Device Procurement Agencies
    • Government Bodies/Municipal Corporations
    • Business Research and Consulting Service Providers
    • Venture Capitalists
    • US Food and Drug Administration (US FDA)
    • European Union (EU)

    Report Objectives

    • To define, describe, and forecast the oxygen concentrators market based on product, modality, patient type, application, end user, and region  
    • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall oxygen concentrators market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the oxygen concentrators market in six regions, namely, North America (US and Canada), Europe (Germany, UK, France, Spain, Italy, and Rest of Europe), the Asia Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), Middle East & Africa, and GCC Countries
    • To strategically profile the key players in the global market and comprehensively analyze their core competencies
    • To track and analyze competitive developments, such as product launches, expansions, agreements, and acquisitions, of the leading players in the market

    Get the Full ECMO Machines Market Report

    Full forecast, segment splits, and company analysis for all ECMO Machines Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status